German billionaire Dietmar Hopp is reportedly preparing to sell medical skin patch maker LTS Lohmann as he looks to shake-up his investment porfolio.
LTS has 1,300 employees and brings in more than 300 million euros ($319 million) in annual sales from nicotine and medical patches that treat conditions such as Parkinson’s and restless legs syndrome. Sources close to the matter told Reuters that Hopps’ investment firm, Dievini, has begun to approach potential buyers and gauge their interest in LTS.
Get the full story at our sister site, Drug Delivery Business News.
The post German billionaire Hopp readies sale of skin patch maker LTS appeared first on MassDevice.